Annual Accounts Receivable
$131.40 K
-$318.20 K-70.77%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual accounts receivable is $131.40 thousand, with the most recent change of -$318.20 thousand (-70.77%) on December 1, 2023.
- During the last 3 years, ADXN annual accounts receivable has risen by +$53.10 thousand (+67.82%).
- ADXN annual accounts receivable is now -86.76% below its all-time high of $992.30 thousand, reached on December 31, 2012.
Performance
ADXN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$570.60 K
-$81.20 K-12.46%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly accounts receivable is $570.60 thousand, with the most recent change of -$81.20 thousand (-12.46%) on September 1, 2024.
- Over the past year, ADXN quarterly accounts receivable has increased by +$369.20 thousand (+183.32%).
- ADXN quarterly accounts receivable is now -42.50% below its all-time high of $992.30 thousand, reached on December 31, 2012.
Performance
ADXN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ADXN Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.8% | +183.3% |
| 3 y3 years | +67.8% | +216.5% |
| 5 y5 years | -52.6% | - |
ADXN Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.8% | at low | -12.5% | +343.0% |
| 5 y | 5-year | -70.8% | +67.8% | -12.5% | +711.7% |
| alltime | all time | -86.8% | +67.8% | -42.5% | +711.7% |
Addex Therapeutics Ltd Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $570.60 K(-12.5%) |
| Jun 2024 | - | $651.80 K(+406.1%) |
| Mar 2024 | - | $128.80 K(-2.0%) |
| Dec 2023 | $131.40 K(-70.8%) | $131.40 K(-34.8%) |
| Sep 2023 | - | $201.40 K(-29.2%) |
| Jun 2023 | - | $284.30 K(+12.7%) |
| Mar 2023 | - | $252.20 K(-43.9%) |
| Dec 2022 | $449.60 K(+149.4%) | $449.60 K(+47.3%) |
| Sep 2022 | - | $305.30 K(-12.2%) |
| Jun 2022 | - | $347.60 K(-12.5%) |
| Mar 2022 | - | $397.30 K(+120.4%) |
| Dec 2021 | $180.30 K(+130.3%) | $180.30 K(-15.4%) |
| Sep 2021 | - | $213.00 K(+55.1%) |
| Jun 2021 | - | $137.30 K(+76.7%) |
| Mar 2021 | - | $77.70 K(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $78.30 K(-35.7%) | $78.30 K(-5.1%) |
| Sep 2020 | - | $82.50 K(-24.5%) |
| Jun 2020 | - | $109.30 K(+55.5%) |
| Mar 2020 | - | $70.30 K(-42.3%) |
| Dec 2019 | $121.80 K(-56.1%) | $121.80 K(-58.4%) |
| Jun 2019 | - | $293.10 K(+5.7%) |
| Dec 2018 | $277.30 K(-11.1%) | $277.30 K(-71.4%) |
| Jun 2018 | - | $968.70 K(+210.5%) |
| Dec 2017 | $312.00 K(+43.8%) | $312.00 K(+43.8%) |
| Dec 2016 | $216.90 K(+62.4%) | $216.90 K(+62.4%) |
| Dec 2015 | $133.60 K(+44.4%) | $133.60 K(+44.4%) |
| Dec 2014 | $92.50 K(-89.9%) | $92.50 K(-89.9%) |
| Dec 2013 | $914.50 K(-7.8%) | $914.50 K(-7.8%) |
| Dec 2012 | $992.30 K(+69.5%) | $992.30 K |
| Dec 2006 | $585.60 K | - |
FAQ
- What is Addex Therapeutics Ltd annual accounts receivable?
- What is the all time high annual accounts receivable for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual accounts receivable year-on-year change?
- What is Addex Therapeutics Ltd quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly accounts receivable year-on-year change?
What is Addex Therapeutics Ltd annual accounts receivable?
The current annual accounts receivable of ADXN is $131.40 K
What is the all time high annual accounts receivable for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual accounts receivable is $992.30 K
What is Addex Therapeutics Ltd annual accounts receivable year-on-year change?
Over the past year, ADXN annual accounts receivable has changed by -$318.20 K (-70.77%)
What is Addex Therapeutics Ltd quarterly accounts receivable?
The current quarterly accounts receivable of ADXN is $570.60 K
What is the all time high quarterly accounts receivable for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly accounts receivable is $992.30 K
What is Addex Therapeutics Ltd quarterly accounts receivable year-on-year change?
Over the past year, ADXN quarterly accounts receivable has changed by +$369.20 K (+183.32%)